NQCCX
Price
$4.09
Change
+$0.03 (+0.74%)
Updated
Sep 4 closing price
Net Assets
24M
VVIAX
Price
$71.19
Change
-$0.24 (-0.34%)
Updated
Sep 5 closing price
Net Assets
202.84B
Interact to see
Advertisement

NQCCX vs VVIAX

Header iconNQCCX vs VVIAX Comparison
Open Charts NQCCX vs VVIAXBanner chart's image
Nuveen Large Cap Value Opportunities C
Price$4.09
Change+$0.03 (+0.74%)
VolumeN/A
Net Assets24M
Vanguard Value Index Adm
Price$71.19
Change-$0.24 (-0.34%)
VolumeN/A
Net Assets202.84B
NQCCX vs VVIAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
NQCCX vs. VVIAX commentary
Sep 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NQCCX is a Buy and VVIAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 203B vs. NQCCX (24M). VVIAX pays higher dividends than NQCCX: VVIAX (2.10) vs NQCCX (0.96). NQCCX was incepted earlier than VVIAX: NQCCX (19 years) vs VVIAX (25 years). NQCCX (2.36) is less costly to investors than VVIAX (0.05). NQCCX is a more actively managed with annual turnover of: 35.00 vs. VVIAX (9.00). NQCCX has a lower initial minimum investment than VVIAX: NQCCX (2500) vs VVIAX (3000). NQCCX annual gain was more profitable for investors over the last year : 12.42 vs. VVIAX (7.74). VVIAX return over 5 years is better than : 70.16 vs. NQCCX (26.03).
NQCCXVVIAXNQCCX / VVIAX
Total Expense Ratio1.750.053,500%
Annual Report Gross Expense Ratio2.360.054,720%
Fund Existence19 years25 years-
Gain YTD14.5667.850186%
Front LoadN/AN/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets24M203B0%
Annual Yield % from dividends0.962.1045%
Returns for 1 year12.427.74161%
Returns for 3 years42.3736.61116%
Returns for 5 years26.0370.1637%
Returns for 10 years-59.70131.61-45%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CPT111.361.02
+0.92%
Camden Property Trust
NNNN47.850.21
+0.44%
Anbio Biotechnology
TMCI7.17N/A
N/A
Treace Medical Concepts
ISRL12.50-0.06
-0.46%
Israel Acquisitions Corp
CNET1.51-0.06
-3.81%
ZW Data Action Technologies Inc